These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 15915460

  • 1. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue.
    Theal JJ, Toosi MN, Girlan L, Heslegrave RJ, Huet PM, Burak KW, Swain M, Tomlinson GA, Heathcote EJ.
    Hepatology; 2005 Jun; 41(6):1305-12. PubMed ID: 15915460
    [Abstract] [Full Text] [Related]

  • 2. Personal view: a potential novel treatment for fatigue complicating chronic liver disease--how should its efficacy be evaluated?
    Jones EA.
    Aliment Pharmacol Ther; 2006 Apr 15; 23(8):1113-6. PubMed ID: 16611271
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 15; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 4. Fatigue in primary biliary cirrhosis: a possible role of comorbidities.
    Biagini MR, Tozzi A, Milani S, Grippo A, Amantini A, Capanni M, Galli A, Surrenti C.
    Eur J Gastroenterol Hepatol; 2008 Feb 15; 20(2):122-6. PubMed ID: 18188032
    [Abstract] [Full Text] [Related]

  • 5. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
    Mendonça DA, Menezes K, Jog MS.
    Mov Disord; 2007 Oct 31; 22(14):2070-6. PubMed ID: 17674415
    [Abstract] [Full Text] [Related]

  • 6. Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634].
    ter Borg PC, van Os E, van den Broek WW, Hansen BE, van Buuren HR.
    BMC Gastroenterol; 2004 Jul 13; 4():13. PubMed ID: 15251034
    [Abstract] [Full Text] [Related]

  • 7. A controlled trial of ondansetron in the pruritus of cholestasis.
    O'Donohue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R.
    Aliment Pharmacol Ther; 2005 Apr 15; 21(8):1041-5. PubMed ID: 15813840
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 15; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications.
    Holman AJ, Myers RR.
    Arthritis Rheum; 2005 Aug 15; 52(8):2495-505. PubMed ID: 16052595
    [Abstract] [Full Text] [Related]

  • 10. Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.
    Newton JL, Gibson GJ, Tomlinson M, Wilton K, Jones D.
    Hepatology; 2006 Jul 15; 44(1):91-8. PubMed ID: 16800007
    [Abstract] [Full Text] [Related]

  • 11. Methodological issues and the measurement of fatigue in primary biliary cirrhosis.
    Revicki DA.
    Hepatology; 2005 Jul 15; 42(1):24-6. PubMed ID: 15962325
    [No Abstract] [Full Text] [Related]

  • 12. Ondansetron and pruritus in chronic liver disease: a controlled study.
    Jones EA, Molenaar HA, Oosting J.
    Hepatogastroenterology; 2007 Jun 15; 54(76):1196-9. PubMed ID: 17629069
    [Abstract] [Full Text] [Related]

  • 13. Modafinil for treatment of fatigue in post-polio syndrome: a randomized controlled trial.
    Vasconcelos OM, Prokhorenko OA, Salajegheh MK, Kelley KF, Livornese K, Olsen CH, Vo AH, Dalakas MC, Halstead LS, Jabbari B, Campbell WW.
    Neurology; 2007 May 15; 68(20):1680-6. PubMed ID: 17502549
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
    Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C.
    J Neurol Sci; 2004 Mar 15; 218(1-2):103-8. PubMed ID: 14759641
    [Abstract] [Full Text] [Related]

  • 15. Ondansetron reduces the craving of biologically predisposed alcoholics.
    Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M.
    Psychopharmacology (Berl); 2002 Apr 15; 160(4):408-13. PubMed ID: 11919668
    [Abstract] [Full Text] [Related]

  • 16. 5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).
    National Cancer Institute of Canada Clinical Trials Group (SC19)National Cancer Institute of Canada Clinical Trials Group, Canada. Rebecca.wong@rmp.uhn.on.ca, Wong RK, Paul N, Ding K, Whitehead M, Brundage M, Fyles A, Wilke D, Nabid A, Fortin A, Wilson D, McKenzie M, Ackerman I, Souhami L, Chabot P, Pater J.
    J Clin Oncol; 2006 Jul 20; 24(21):3458-64. PubMed ID: 16849762
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG, Riley DS, Heger M.
    Explore (NY); 2007 Jul 20; 3(6):573-84. PubMed ID: 18005909
    [Abstract] [Full Text] [Related]

  • 18. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence.
    Johnson BA, Roache JD, Ait-Daoud N, Javors MA, Harrison JM, Elkashef A, Mojsiak J, Li SH, Bloch DA.
    Drug Alcohol Depend; 2006 Oct 01; 84(3):256-63. PubMed ID: 16631323
    [Abstract] [Full Text] [Related]

  • 19. Pruritus and fatigue associated with liver disease: is there a role for ondansetron?
    Jones EA.
    Expert Opin Pharmacother; 2008 Mar 01; 9(4):645-51. PubMed ID: 18312165
    [Abstract] [Full Text] [Related]

  • 20. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A, Ma C, Ahdieh H, Galer BS.
    Clin Ther; 2006 Mar 01; 28(3):352-64. PubMed ID: 16750450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.